Molecular drill bits attack tuberculosis

The peptides attack tuberculosis bacteria by drilling holes in their cell membranes © A Dowsett, Public Health England / Science Photo Library

Peptides that punch through bacterial cell walls while leaving human cells unharmed could open up new ways to tackle antibiotic resistance, say researchers in the US. Using bioinformatics and protein engineering, one group have designed and synthesised three of these peptides that show promising activity against TB-causing Mycobacterium tuberculosis.

Dubbed ‘molecular drill bits’ because of the way they penetrate bacterial cell membranes, anti microbial peptides (AMPs) have been of interest for several years, says Georges Belfort from Rensselaer Polytechnic Institute who presented the work at the 247th ACS National Meeting & Exposition in Dallas, US. ‘These are small peptides – around 10–50 amino acids long – that are produced in nature by all kinds of organisms including humans,’ says Belfort. ‘The question we wanted to ask is can we rationally design them for use against specific bacteria?’

In 2012, Belfort came across a paper published by a different group, who had used a bioinformatics process to filter information on promising AMPs from papers and databases.1 Belfort’s team used this method to gather information on what kinds of AMPs might be effective against TB. ‘Peptides that are about 13 amino acids long, which is half the thickness of the bacterial membrane, work well, so that was the size we decided to go for,’ says Belfort. Composition-wise the peptides must include positively charged residues, as well as hydrophobic regions. ‘Bacterial membranes are negatively charged on the outside, so you have to have a positive charge,’ he explains. ‘Mammalian cell membranes are neutral, which is why they are not attacked very easily by these peptides. You also need to have some hydrophobicity to get into the lipid bilayer and disturb it.’

Taking these factors into consideration, Belfort and his colleagues were able to carefully choose and position each amino acid in their peptides. They constructed three new AMPs this way, all of which killed M. tuberculosis and M. smegmatis, a fast growing analogue of TB, in tests. One AMP was more effective than the others, and also killed Escherichia coli cells. The group have applied for a patent for the methodology and the three peptides they made.

‘In the ongoing battle against emerging antibiotic resistant bacteria, antimicrobial peptides represent a potentially powerful new class of antibiotics,’ says Monique van Hoek, who works on AMPs at George Mason University in the US. She adds that applying this database filtration approach to other bacterial species will help improve understanding of how AMPs work and the importance of different properties such as charge and hydrophobicity.

Related Content

Be careful what you wish for

1 April 2012 Comments

news image

The struggle for a single unitary European patent may be close to an end, but we must still hold out for an agreement that pe...

Dual warhead kills and disarms bacteria

29 May 2014 Research

news image

Compound damages bacterial membrane and disables resistance mechanism in a two-pronged attack

Most Read

Coated nanoparticles show Alzheimer's promise

12 September 2014 News and Analysis

news image

Gold nanoparticles functionalised with amino acid polymer inhibit the growth of amyloid fibres associated with neurodegenerat...

First flexible graphene display paves the way for folding electronics

11 September 2014 News and Analysis

news image

Team behind the bendy e-reader display hope to have a full colour graphene-based smartphone style screen within a year

Most Commented

Does life play dice?

3 September 2014 The Crucible

news image

Philip Ball wonders whether life evolved to exploit quantum phenomena, or if it’s just in our nature

The trouble with boycotts

29 August 2014 Critical Point

news image

Cutting academic ties with a censured state can do more harm than good, says Mark Peplow